Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Non-destructive, label free identification of cell cycle phase in cancer cells by multispectral microscopy of autofluorescence.

Campbell JM, Habibalahi A, Mahbub S, Gosnell M, Anwer AG, Paton S, Gronthos S, Goldys E.

BMC Cancer. 2019 Dec 21;19(1):1242. doi: 10.1186/s12885-019-6463-x.

2.

Conditional knockout of ephrinB1 in osteogenic progenitors delays the process of endochondral ossification during fracture repair.

Arthur A, Paton S, Zannettino ACW, Gronthos S.

Bone. 2020 Mar;132:115189. doi: 10.1016/j.bone.2019.115189. Epub 2019 Dec 19.

3.

The transfer of unsterilized material from Mars to Phobos: Laboratory tests, modelling and statistical evaluation.

Patel MR, Pearson VK, Evans DJ, Summers DJ, Paton S, Truscott P, Pottage T, Bennett A, Gow JPD, Goodyear MD, Mason JP, Leese MR, Patel RD.

Life Sci Space Res (Amst). 2019 Nov;23:112-134. doi: 10.1016/j.lssr.2019.08.002. Epub 2019 Aug 20.

4.

Lightning is a major cause of large tree mortality in a lowland neotropical forest.

Yanoviak SP, Gora EM, Bitzer PM, Burchfield JC, Muller-Landau HC, Detto M, Paton S, Hubbell SP.

New Phytol. 2020 Mar;225(5):1936-1944. doi: 10.1111/nph.16260. Epub 2019 Nov 18.

PMID:
31610011
5.

Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage ratesĀ in a laboratory model system.

Aranega-Bou P, George RP, Verlander NQ, Paton S, Bennett A, Moore G; TRACE Investigators' Group.

J Hosp Infect. 2019 May;102(1):63-69. doi: 10.1016/j.jhin.2018.12.007. Epub 2018 Dec 18.

6.

Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance.

Arthur A, Nguyen TM, Paton S, Zannettino ACW, Gronthos S.

Exp Hematol. 2019 Jan;69:43-53. doi: 10.1016/j.exphem.2018.10.004. Epub 2018 Oct 13.

7.

The osteoprogenitor-specific loss of ephrinB1 results in an osteoporotic phenotype affecting the balance between bone formation and resorption.

Arthur A, Nguyen TM, Paton S, Klisuric A, Zannettino ACW, Gronthos S.

Sci Rep. 2018 Aug 24;8(1):12756. doi: 10.1038/s41598-018-31190-2.

8.

Sampling and inactivation of wet disseminated spores from flooring materials, using commercially available robotic vacuum cleaners.

Thompson KA, Paton S, Pottage T, Bennett AM.

J Appl Microbiol. 2018 Oct;125(4):1030-1039. doi: 10.1111/jam.13910. Epub 2018 Aug 2.

PMID:
29742310
9.

Pentosan polysulfate binds to STRO-1+ mesenchymal progenitor cells, is internalized, and modifies gene expression: a novel approach of pre-programing stem cells for therapeutic application requiring their chondrogenesis.

Wu J, Shimmon S, Paton S, Daly C, Goldschlager T, Gronthos S, Zannettino ACW, Ghosh P.

Stem Cell Res Ther. 2017 Dec 13;8(1):278. doi: 10.1186/s13287-017-0723-y.

10.

A climate change adaptation strategy for management of coastal marsh systems.

Wigand C, Ardito T, Chaffee C, Ferguson W, Paton S, Raposa K, Vandemoer C, Watson E.

Estuaries Coast. 2017 Jan 5;40(3):682-693.

11.

Loss of ephrinB1 in osteogenic progenitor cells impedes endochondral ossification and compromises bone strength integrity during skeletal development.

Nguyen TM, Arthur A, Paton S, Hemming S, Panagopoulos R, Codrington J, Walkley CR, Zannettino AC, Gronthos S.

Bone. 2016 Dec;93:12-21. doi: 10.1016/j.bone.2016.09.009. Epub 2016 Sep 10.

PMID:
27622886
12.

Accelerated Hepatitis A and B Immunization in a Substance Abuse Treatment Program.

Winn JL, Francis EM, Shealy SE, Levarge M, Paton S, Planner A, Kelly K, Gonzales-Nolas C.

Fed Pract. 2015 Aug;32(8):38-43.

13.

EphB4 Expressing Stromal Cells Exhibit an Enhanced Capacity for Hematopoietic Stem Cell Maintenance.

Nguyen TM, Arthur A, Panagopoulos R, Paton S, Hayball JD, Zannettino AC, Purton LE, Matsuo K, Gronthos S.

Stem Cells. 2015 Sep;33(9):2838-49. doi: 10.1002/stem.2069. Epub 2015 Jun 23.

14.

Reaerosolization of Spores from Flooring Surfaces To Assess the Risk of Dissemination and Transmission of Infections.

Paton S, Thompson KA, Parks SR, Bennett AM.

Appl Environ Microbiol. 2015 Aug;81(15):4914-9. doi: 10.1128/AEM.00412-15. Epub 2015 May 15.

15.

Development of a sporicidal test method for Clostridium difficile.

Fraise AP, Wilkinson MA, Bradley CR, Paton S, Walker J, Maillard JY, Wesgate RL, Hoffman P, Coia J, Woodall C, Fry C, Wilcox M.

J Hosp Infect. 2015 Jan;89(1):2-15. doi: 10.1016/j.jhin.2014.09.014. Epub 2014 Oct 24.

PMID:
25477061
16.

Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.

Richardson JD, Psaltis PJ, Frost L, Paton S, Carbone A, Bertaso AG, Nelson AJ, Wong DT, Worthley MI, Gronthos S, Zannettino AC, Worthley SG.

Cytotherapy. 2014 Apr;16(4):460-70. doi: 10.1016/j.jcyt.2013.07.016. Epub 2013 Oct 8.

PMID:
24113430
17.

Cardiac magnetic resonance, transthoracic and transoesophageal echocardiography: a comparison of in vivo assessment of ventricular function in rats.

Richardson JD, Bertaso AG, Frost L, Psaltis PJ, Carbone A, Koschade B, Wong DT, Nelson AJ, Paton S, Williams K, Azarisman S, Worthley MI, Teo KS, Gronthos S, Zannettino AC, Worthley SG.

Lab Anim. 2013 Oct;47(4):291-300. doi: 10.1177/0023677213494373. Epub 2013 Jul 8.

PMID:
23836849
18.

Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction.

Richardson JD, Bertaso AG, Psaltis PJ, Frost L, Carbone A, Paton S, Nelson AJ, Wong DT, Worthley MI, Gronthos S, Zannettino AC, Worthley SG.

J Card Fail. 2013 May;19(5):342-53. doi: 10.1016/j.cardfail.2013.03.011.

PMID:
23663817
19.

Is routine alcohol screening and brief intervention feasible in a New Zealand primary care environment.

Gifford H, Paton S, Cvitanovic L, McMenamin J, Newton C.

N Z Med J. 2012 May 11;125(1354):17-25.

PMID:
22595920
20.

Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in Northern Saskatchewan, Canada.

Golding GR, Quinn B, Bergstrom K, Stockdale D, Woods S, Nsungu M, Brooke B, Levett PN, Horsman G, McDonald R, Szklarczuk B, Silcox S, Paton S, Carson M, Mulvey MR, Irvine J; Northern Antibiotic Resistance Partnership.

BMC Public Health. 2012 Jan 6;12:15. doi: 10.1186/1471-2458-12-15.

21.

A comparison of sexual and reproductive health services provided by genitourinary and family planning clinics for adolescents.

Paton SL, Fernando I, Lamont RF.

Int J STD AIDS. 2010 Sep;21(9):642-7. doi: 10.1258/ijsa.2010.010189.

PMID:
21097738
22.

Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells.

Zannettino AC, Paton S, Itescu S, Gronthos S.

Tissue Eng Part A. 2010 Dec;16(12):3579-87. doi: 10.1089/ten.TEA.2010.0153. Epub 2010 Aug 30.

PMID:
20666614
23.

Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice.

Mauck B, Lucot JB, Paton S, Grubbs RD.

Neurotoxicology. 2010 Sep;31(5):461-7. doi: 10.1016/j.neuro.2010.06.001. Epub 2010 Jun 11.

PMID:
20542057
24.

Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada.

Raboud J, Shigayeva A, McGeer A, Bontovics E, Chapman M, Gravel D, Henry B, Lapinsky S, Loeb M, McDonald LC, Ofner M, Paton S, Reynolds D, Scales D, Shen S, Simor A, Stewart T, Vearncombe M, Zoutman D, Green K.

PLoS One. 2010 May 19;5(5):e10717. doi: 10.1371/journal.pone.0010717.

25.

Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.

Psaltis PJ, Paton S, See F, Arthur A, Martin S, Itescu S, Worthley SG, Gronthos S, Zannettino AC.

J Cell Physiol. 2010 May;223(2):530-40. doi: 10.1002/jcp.22081.

PMID:
20162565
26.

Establishment of a low birth weight registry and initial outcomes.

Eisenhauer E, Uddin DE, Albers P, Paton S, Stoughton RL.

Matern Child Health J. 2011 Oct;15(7):921-30. doi: 10.1007/s10995-009-0540-8.

PMID:
19908132
27.

Caring for severe acute respiratory syndrome (SARS) patients in acute care institutions in the greater Toronto area.

Nicolle LE, Perkins P, Gravel D, Paton S, Christian M, Ofner M, Henry B, McGeer A, Vearncombe M, Simor A, Barry C, Mederski B.

Can Commun Dis Rep. 2008 Dec;34(12):1-17. English, French. No abstract available.

28.

Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues.

Gronthos S, McCarty R, Mrozik K, Fitter S, Paton S, Menicanin D, Itescu S, Bartold PM, Xian C, Zannettino AC.

Stem Cells Dev. 2009 Nov;18(9):1253-62. doi: 10.1089/scd.2008.0400.

PMID:
19327008
29.

Central venous catheter-associated bloodstream infections occurring in Canadian intensive care units: A six-month cohort study.

Holton D, Paton S, Conly J, Embree J, Taylor G, Thompson W.

Can J Infect Dis Med Microbiol. 2006 May;17(3):169-76.

30.

The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998.

Conly JM, Ofner-Agostini M, Paton S, Johnston L, Mulvey M, Kureishi A, Nicolle L, Matlow A; Canadian Hospital Epidemiology Commmittee; Canadian Nosocomial Infection Surveillance Program.

Can J Infect Dis. 2001 Nov;12(6):364-70.

31.

N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Hyland M, Ofner-Agostini M, Miller M, Paton S, Gourdeau M, Ishak M; Canadian Hospital Epidemiology Committee; Canadian Nosocomial Infection Surveillance Program (Health Canada).

Can J Infect Dis. 2001 Mar;12(2):81-8.

32.

Diurnal behavioral and endocrine effects of chronic shaker stress in mice.

Dubovicky M, Mach M, Key M, Morris M, Paton S, Lucot JB.

Neuro Endocrinol Lett. 2007 Dec;28(6):846-53.

PMID:
18063939
33.
34.

Acinetobacter baumannii in casualties returning from Afghanistan.

Stuart TL, Mulvey M, Simor AE, Tien HC, Battad A, Taylor G, Vayalumkal JV, Weir C, Ofner M, Gravel D, Paton S.

Can J Infect Control. 2007 Fall;22(3):152-4.

PMID:
18044384
35.

Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo.

Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S.

J Cell Physiol. 2008 Feb;214(2):413-21.

PMID:
17654479
36.

Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment.

Shiffman S, Balabanis MH, Gwaltney CJ, Paty JA, Gnys M, Kassel JD, Hickcox M, Paton SM.

Drug Alcohol Depend. 2007 Dec 1;91(2-3):159-68. Epub 2007 Jul 12.

37.

ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.

Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, Simor AE, Paton S, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

FEMS Microbiol Lett. 2007 May;270(2):265-71. Epub 2007 Feb 26.

38.

Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004.

Wu HX, Wu J, Wong T, Andonov A, Li Q, Dinner K, Donaldson T, Paton S; Enhanced Hepatitis Strain Surveillance System (c/o Ms. Marlene Huard, Executive Assistant).

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):167-74.

PMID:
17308895
39.
40.

Survival analysis of liver transplant patients in Canada 1997-2002.

Hong Z, Wu J, Smart G, Kaita K, Wen SW, Paton S, Dawood M.

Transplant Proc. 2006 Nov;38(9):2951-6.

PMID:
17112872
41.

Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada: a public health laboratory study.

Dawood M, Smart G, Wood M, Wu HX, Paton S, Wu J.

Can J Microbiol. 2006 Oct;52(10):999-1005.

PMID:
17110969
42.

Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.

Wu HX, Wu J, Wong T, Donaldson T, Dinner K, Andonov A, Ip Chan J, Moffat B, Baptiste B, Furseth J, Poliquin D, Bolesnikov G, Giulivi A, Paton S.

Scand J Infect Dis. 2006;38(6-7):482-9.

PMID:
16798699
43.

Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series.

Ofner-Agostini M, Gravel D, McDonald LC, Lem M, Sarwal S, McGeer A, Green K, Vearncombe M, Roth V, Paton S, Loeb M, Simor A.

Infect Control Hosp Epidemiol. 2006 May;27(5):473-8. Epub 2006 Apr 26.

PMID:
16671028
44.

Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers.

Shiffman S, Scharf DM, Shadel WG, Gwaltney CJ, Dang Q, Paton SM, Clark DB.

J Consult Clin Psychol. 2006 Apr;74(2):276-85.

PMID:
16649872
45.

Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people.

Ofner-Agostini M, Simor AE, Mulvey M, Bryce E, Loeb M, McGeer A, Kiss A, Paton S; Canadian Nosocomial Infection Surveillance Program, Health Canada.

Infect Control Hosp Epidemiol. 2006 Feb;27(2):204-7. Epub 2006 Feb 8.

PMID:
16465642
46.

Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients.

Simor AE, Ofner-Agostini M, Paton S, McGeer A, Loeb M, Bryce E, Mulvey M; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2005 Oct;26(10):838-41.

PMID:
16276960
47.

Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003.

Wu HX, Andonov A, Giulivi A, Goedhuis NJ, Baptiste B, Furseth J, Poliquin D, Chan JI, Bolesnikov G, Moffat B, Paton S, Wu J.

Int J Med Sci. 2005;2(4):143-6. Epub 2005 Oct 1.

48.

Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units.

Booth TF, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, Li Y, Spence M, Paton S, Henry B, Mederski B, White D, Low DE, McGeer A, Simor A, Vearncombe M, Downey J, Jamieson FB, Tang P, Plummer F.

J Infect Dis. 2005 May 1;191(9):1472-7. Epub 2005 Mar 18.

PMID:
15809906
49.

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals.

Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, Paton S.

Antimicrob Agents Chemother. 2005 Jan;49(1):358-65.

50.

Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.

Mach M, Grubbs RD, Price WA, Paton SJ, Lucot JB.

Pharmacol Biochem Behav. 2004 Nov;79(3):533-40.

PMID:
15582025

Supplemental Content

Support Center